AbolerIS Pharma will develop novel and unique therapeutic approaches to induce immune tolerance and preserves useful immune responses in inflammatory, autoimmune and degenerative diseases.

Anti-CD45RC monoclonal antibody to deplete effector T cells and preserve regulatory and memory T cells.

IL-34 cytokine to induce tolerogenic macrophages/DCs and regulatory T cells.

Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance.

Biotechnology

AbolerIS Pharma

AbolerIS Pharma's headquarters in Nantes, France

Ann Meulemans

Benoit Moreaux

Philippe Alen

Carole Guillonneau

Olivier Van de Steen

Michel Goldman

F.-Xavier Hubert

Hans-Dieter Volk

Guy Heynen

Bervin Bouani

Roland Buelow

This department oversees and guides the organization's strategic direction and decision-making processes.

Leadership Group

This department oversees the strategic direction and governance of the organization through board-related activities.

Board Governance

The Leadership Team at AbolerIS Pharma consists of the CEO, three Founders, and the CFO. This team is responsible for setting the strategic direction of the company, ensuring financial stability, and fostering innovation in developing unique therapeutic approaches to induce immune tolerance. They leverage their extensive expertise in regulatory T cells and mechanisms of tolerance to steer AbolerIS Pharma towards its goal of addressing inflammatory, autoimmune, and degenerative diseases.

Leadership Team

This department focuses on managing and overseeing biotechnological processes and operations to support research and development.

Biotechnology Operations

The Research and Development team at AbolerIS Pharma focuses on pioneering innovative therapeutic strategies to achieve immune tolerance. They work on the development and optimization of treatments such as the anti-CD45RC monoclonal antibody and IL-34 cytokine, aiming to selectively target and modulate immune responses in inflammatory, autoimmune, and degenerative diseases. This team utilizes their extensive expertise in regulatory T cells and tolerance mechanisms to advance clinical applications and translational research.

AbolerIS Pharma

Org chart

Board & advisors

Teams

Leadership Group

Board Governance

Leadership Team

Biotechnology Operations

Research and Development

Offices

AbolerIS Pharma

Org chart

Board & advisors

Teams

Leadership Group

Board Governance

Leadership Team

Biotechnology Operations

Research and Development

Offices

Related companies